reported that cluster II (luminal infiltrated) and III (basal) tumors responded better to nivolumab [94]. feminine pets [12]. Castrated male mice adopt the feminine design of response to BBN, which may be reversed by testosterone treatment. Conversely, testosterone-treated feminine mice show the male design of response to BBN [12]. Furthermore, Continue Reading